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Introduction
The development of new antifungal drugs is urgent and
challenging[1,2] because hosts and invading fungi may have
similar cellular, physiological, and metabolic characteristics.
Consequently, novel antimycotics that target specific fungi
selectively and without side effects are required. During the
last two decades, a broad range of antimicrobial proteins
(peptides, AMPs) from different organisms, ranging from
bacteria to humans, have been isolated and characterized.
The number of known AMPs rapidly increased to a value
above 4000, and approximately 600 of them have antifungal
activity.[3] However, in spite of the numerous studies of
homologous antifungal proteins,[4] the striking differences in
their mode of action have not yet been disclosed.
PAF, an antifungal protein from Penicillium chrysogenum,
is a cysteine-rich, cationic 55-mer protein.[5,6] It was previ-
ously observed that PAF can effectively inhibit the growth
of numerous filamentous fungi causing membrane perme-
ACHTUNGTRENNUNGabilization, intracellular oxidative stress, and evoking pro-
grammed cell death through a G-protein signal-transduction
pathway.[7] PAF is harmless for mammals, as proven in our
recent PET (positron emission tomography) experiments.[8]
Therefore, PAF is promising for the treatment of mycoses
and fungal infections, especially against aspergillosis. The
structure of PAF is stabilized by three disulfide bridges,
which are essential for biological activity.[6] Chemical synthe-
sis is not only a straightforward and convincing verification
of the disulfide-bond pattern, but also allows the production
of unusual “mutants” that cannot be produced by heterolo-
gous expression.
The chemical synthesis peptides containing multiple disul-
fides in a regioselective manner is still a challenging task for
peptide chemists, although recently many improvements
were described in the literature.[9,10] The strategies involve
either directed oxidative folding from polythiol precursors
or stepwise introduction of the desired disulfide bonds using
orthogonal protecting groups for the cysteine thiols.[11,12]
Both strategies can be carried out in the liquid phase or,
rarely, on solid phase.[13,14] The oxidative folding of fully de-
protected linear peptides is a commonly applied approach;
however, generation of the desired disulfide-bond pattern
through this approach is not always possible.[15] Orthogonal
protection is more efficient in these cases, but the applicabil-
ity of the numerous thiol protecting groups for efficient re-
gioselective protection schemes is still restricted.
Herein, we describe the first successful chemical synthesis
of PAF. Many routinely applied synthetic methods failed in
our hands in the preparation of this miniprotein. Stepwise
solid-phase synthesis has not provided the full-length pep-
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tide with acceptable yield; native chemical ligation had to
be applied instead. Another challenge was to form the natu-
ral disulfide-bridge pattern. In addition to structure verifica-
tion and biological activity checks of the products, we dis-
cuss solutions for the unexpected problems in the synthetic
work.[16]
Results and Discussion
Disulfide bonds are essential for the folding of small pro-
teins. Determination of the redox state of cysteine residues
is straightforward by either mass spectrometry[17–20] or NMR
spectroscopy.[19,20] However, identification of the disulfide
(SS) pattern by enzymatic digestion followed by mass spec-
trometry may be difficult because of the extreme stability of
some disulfide proteins, especially PAF. X-ray diffraction is
difficult to apply to small proteins, because of crystallization
problems. Earlier, NMR studies could not be used to fully
disclose the SS pattern in the case of two homologous pro-
teins PAF and AFP. This is because the CbCb distances be-
tween SS-linked cysteine residues obtained from the NOE-
constrained structure calculations (CYANA[21,22]) may allow
different SS patterns in the congested hydrophobic core of
the two proteins. Therefore, to allow concurrent patterns,
the structure of PAF[6] (pdb code: 2kcn) was published with-
out explicit disulfide bonds, as was the case for AFP[23] (pdb
code: 1afp). There are ongoing NMR studies using 15N/13C
labeled PAF, combined with molecular dynamics calcula-
tions, in an effort to prove the PAF disulfide pattern solely
by NMR spectroscopy. Until now, the results were in ac-
cordance with the preferred abcabc pattern and gave a root
mean square deviation (RMSD) for backbone atoms of
0.440.14  for the final ensemble of NMR-constrained
CYANA calculations; a separate structural paper is in prep-
aration. In principle, the NMR approach[24] is preferred for
small proteins; however, NOE correlations between cova-
lently linked Cys residues can hardly be measured because
the rate of intraresidue geminal cross relaxation involving
the Cys b-protons is much higher than that of inter-residue
relaxation.[2] Exact measurement of long-range NOE corre-
lations with the aid of stereospecific deuterium labeling of
Cys b-protons and deuterium labeling at other carbon atoms
in 13C-labeled BPTI was proposed recently.[25] Alternative
NMR approaches involving the mutation of cysteine into se-
lenocysteine residues (heterologous expression or chemical
synthesis) have also been suggested.[26] Still, the most
straightforward and convincing verification of the SS pattern
of a particular protein may be through direct chemical syn-
thesis. In fact, only the combination of mass spectrometric
and NMR analysis can prove unequivocally the preferred
abcabc pattern in the case of both native and synthetic PAF
(Figure 1). Furthermore, rearrangement of disulfide bonds
in other synthetic ways can prevent the production of PAF
with the correct fold. One concurrent (abbacc) pattern
could be excluded on the basis of the physical properties of
the wrong synthetic PAF. In the case of native PAF, the DI-
SULFIND bioinformatics server predicted the abcabc pat-
tern with the highest confidence (0.66 versus 0.35 for
abcacb). However, in general, correct folding is not required
for determining the SS pattern of linear peptides or their
mutants with a lower number of possible disulfide
bonds.[27,28] The synthesis of proteins allows insertion of un-
usual residues; for example, the incorporation of selenocys-
teine residues allows conformational studies of disulfide
bonds and that of fluorophenylalanine can facilitate in-cell
NMR investigations.
The present study is important because verification of the
PAF SS pattern could be used to confirm the pattern of
homologous proteins such as AFP and NFAP. The spontane-
ous refolding of linear PAF, the biological activity of syn-
thetic PAF, and the identical tertiary structures of native
and synthetic PAF are interesting.
The following abbreviations are used throughout the
paper: “Native PAF” refers to the naturally folded minipro-
tein isolated from a biological source; “linear PAF” refers
to the reduced form of native PAF; “PAF-C3” refers to syn-
thetic PAF having the natural connectivity of three disulfide
bonds; “PAF-C1” and “PAF-C2” refer to synthetic peptides
containing one and two disulfide bridges, respectively;
“PAF-L” refers to the unfolded synthetic peptide bearing six
sulfhydryl groups. Protecting groups are indicated in paren-
theses if they exist.
Chemical synthesis of unfolded PAF : The first attempt to
prepare PAF was stepwise synthesis on solid phase. Being a
55-mer protein, PAF is close to the limit in peptide length
for preparation using the stepwise method. In accordance
with this, an effective technique, microwave-assisted auto-
matic Fmoc (fluorenylmethoxycarbonyl)-based synthesis
using HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethy-
luronium hexafluorophosphate)/HOBt (1-hydroxybenzotria-
zole) activation did not lead to the desired product. Boc
(tert-butoxycarbonyl)-based chemistry was found to be more
successful. However, the yield of purified PAF-L was only
approximately 1.5% relative to the crude protein (see the
Supporting Information, Figure S1). The length of the pep-
tide together with the sequence might explain the failure of
the syntheses. Furthermore, there are only 11 amino acids in
the Fmoc protocol and 17 in the Boc protocol that can be
used without side-chain protection in solid-phase synthesis.
Therefore, the steric hindrance of larger protecting groups
may decrease the efficacy of acylation.
The low yield of product obtained by using the stepwise
synthesis prompted us to use native chemical ligation
(NCL). NCL, introduced by Kent and co-workers, is a revo-
Figure 1. ACHTUNGTRENNUNG(Top) Supposed disulfide-bond connectivity of PAF: abcabc.
(Bottom) The most probable concurrent pattern of PAF: abbacc.
Chem. Eur. J. 2013, 19, 12684 – 12692  2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemeurj.org 12685
FULL PAPER
lutionary method for the synthesis of relatively long pepti-
des and proteins.[29,30] This method combines the advantages
of stepwise and convergent peptide synthesis.[31] Stepwise
solid-phase synthesis is usually limited to peptides of about
50 amino acids long owing to by-product formation and in-
complete reactions. But the integration of stepwise solid-
phase synthesis with the benefits of a convergent strategy
enables the preparation of full-size proteins. Native chemical
ligation of a peptide a-thioester (N-terminal fragment) and
a Cys-peptide (C-terminal fragment) is based on a thiol-cat-
alyzed thiol–thioester exchange and subsequent S!N acyl
transfer (amide bond formation). PAF contains six cysteine
residues at positions 7, 14, 28, 36, 43, and 54. PAF was cut
into two fragments next to Cys-28. The C-terminal fragment
(P28–55), which includes Cys-28 at the N-terminus, was syn-
thesized according to standard solid-phase Boc chemistry.
The average yield of the purified peptide was 11%. The key
building block in NCL is the thioester of the N-terminal
fragment which, in most cases, is prepared with the use of 3-
mercaptopropanoic (3-MPA) acid by using Boc-based proto-
cols.[32, 33] A generalized version of this method is the appli-
cation of trityl-associated mercaptopropanoic-acid leucine
(TAMPAL) resin.[34] According to this method, a preloaded
leucine resin is acylated with S-tritylmercaptopropanoic
acid, the trityl group is removed by using TFA (trifluoroace-
tic acid), and the C-terminal amino acid is coupled to the
SH group of cysteine, thus forming a thioester bond. Herein
a modified method is discussed for the synthesis of the key
component of NCL. Cys-SH resin, a universally applicable
solid support, has been used for the Boc-based synthesis of
peptide thioesters. When using the Cys-SH resin, the sulf-
hydryl group of a cysteine residue is used as thiol compo-
nent of the thioester (Scheme 1). Using this simple and
easy-to-use protocol, Fmoc-Cys ACHTUNGTRENNUNG(Trt)-OH was first coupled
to MBHA (methylbenzhydrylamino) resin. Then, the Fmoc
group was exchanged for an acetyl group through piperidine
treatment and subsequent acetyl capping. Then, the trityl
group was cleaved by using TFA and the C-terminal amino
acid of the N-terminal fragment was coupled to the un-
blocked sulfhydryl group of cysteine. The same procedure as
that used for the formation of normal oxoesters could be
followed: double coupling with DCC (dicyclohexylcarbodi-
ACHTUNGTRENNUNGimide)/HOBt activation in the presence of a catalytic
amount of 4-DMAP (4-dimethylaminopyridine). The re-
maining free sulfhydryl groups cannot be detected by color
tests, but, according to a newly published method, the cou-
pling efficiency can be determined by NMR spectroscopy.[35]
However, in the case of protected a-amino acids that are
routinely used in SPPS (solid-phase peptide synthesis), the
quantitative assessment of the resin is unnecessary because
the SH group is completely acylated under the reactions
conditions given above. The peptide chain can be built up
on the preloaded Cys-SH resin following standard Boc pro-
tocols. There is no need for special reagents or resins, this
general and simple method being suitable for any C-termi-
nal amino acid. N-acetylcysteine, the leaving group of the
thioester, is an easily treatable by-product of the ligation.
The average yield of the purified peptide was 12%.
After the solid-phase synthesis, native chemical ligation of
the purified fragments was carried out in ammonium acetate
buffer at pH 7.5 in the presence of thiophenol. The strongly
cationic fragments of PAF were soluble in the buffer with-
out the need for adding guanidine hydrochloride. After the
reaction went to completion (4–5 h), the mixture was puri-
fied by semipreparative HPLC so as to gain pure, unfolded
PAF. Native chemical ligation provided a 48% average yield
relative to the purified fragments.
The preparation of all of the differently protected pep-
ACHTUNGTRENNUNGtides, that is, PAF where all Cys residues are protected with
the same protecting group and PAF where the cysteine resi-
dues are protected selectively by using multiple protecting
groups, was carried out according to the protocol discussed
above. The synthesized peptides are summarized in Figure 2.
Comparing the two strategies, native chemical ligation re-
sulted in about 3–4 times greater yield for the preparation
of PAF relative to stepwise synthesis. Furthermore, the ease
of purification of higher-quality crude peptide products also
confirms the superiority of NCL.
Folding of PAF by selective protection of cysteine residues :
Cysteine-rich peptides, in most cases, are synthesized by re-
gioselective methods to ensure correct folding. Several
issues had to be considered in the selection of protecting
groups: compatibility of protecting groups with Boc chemis-
try and their stability against acids such as TFA and liquid
HF. Those protecting groups that are cleavable by thiols
could not be used because of the external thiol reagent in
NCL.
On our first attempt, we applied the following set of pro-
tecting groups: Mbzl (p-methylbenzyl), Fm (fluorenylmeth-
yl), and Acm (acetamidomethyl).[36,37] Mbzl is cleaved in
parallel to the detachment of the peptide from the solid sup-
port, Fm is sensitive to base, and Acm can be removed by
Scheme 1. Synthesis of peptide thioester P1–27 on the universally appli-
cable Cys-SH resin. 2ClZ=2-chlorobenzyloxycarbonyl, DMS=dimethyl-
sulfide, DTT=dithiothreitol, Trt= trityl.
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using iodine, thallium ACHTUNGTRENNUNG(III)-trifluoroacetate, silver(I), or mer-
cury(II) salts.[38] Following purification of the ligation prod-
uct, oxidation of the formerly Mbzl-protected cysteine resi-
dues (Cys28,54) was carried out with intense stirring of a
NH4OAc buffer solution of the ligated product under an air
atmosphere for 24 hours. The resulting solution was lyophi-
lized three times to remove NH4OAc. After that, Cys(Fm)
residues (Cys14, 43) were deprotected and oxidized by treat-
ment with 10 or 20% (v/v) piperidine in DMF (dimethylfor-
mamide) or ACN (acetonitrile) for 30 minutes, followed by
overnight treatment with 2% (v/v) piperidine in DMF or
ACN buffered with AcOH to pH 8.[13] Surprisingly, rear-
rangement of the previously formed disulfide bridge has
been observed by mass spectrometry analysis (see the Sup-
porting Information, Table S1). We tried to use smaller con-
centrations of piperidine (10 or 15%) or DBU (1,8-
diazabicyclo ACHTUNGTRENNUNG[5.4.0]undec-7-ene) (1–5% solution in ACN).
Moreover, the exposure time of the disulfide bridge to basic
conditions was decreased to only one hour by the use of
K3[Fe(CN)6] oxidation for 30 minutes after the removal of
the Fm groups; however, none of these attempts led to the
desired product. Owing to the failure of appropriate folding,
we attempted to build in the other disulfide bridge (Cys7,36)
in the second stage. Iodine treatment successfully cleaved
the Acm groups and oxidized the free SH groups to produce
the second disulfide bridge. Mass spectrometry analysis re-
vealed the correct SS pattern for the formed peptide, PAF-
ACHTUNGTRENNUNG(Fm2)-C2. As the last step of the synthesis, the Fm groups
had to be removed with the use of a base. We hoped to
avoid rearrangement if the structure was stabilized by two
SS bridges under the conditions of basic treatment. Contrary
to our expectations, unnatural disulfides bonds were formed
(Figure 3). We concluded that PAF does not tolerate basic
treatment; consequently, Fm could not be a protecting
group of choice for the orthogonal protection of this mini-
protein.
On our second attempt, we replaced the Fm group with
the enzyme-cleavable S-phenylacetamidomethyl (Phacm)
group.[39] Phacm has the same properties as Acm, thus, it is
compatible with both Boc and Fmoc protocols. Moreover,
Phacm can be selectively cleaved enzymatically by penicil-
lin G amidase (PGA) (EC 3.5.1.11). The use of biocatalysts
is advantageous because it ex-
tends the prospects of orthogo-
nal protection in peptide chem-
istry. The formation of the first
disulfide bond was carried out
according to the procedure
above. Because under the Acm-
deprotection conditions, Phacm
is also cleaved, Phacm had to
be removed prior to Acm. To
cleave the Phacm group, immo-
bilized PGA from E. coli was
applied.[40]
Different conditions were tried for the enzymatic cleav-
age: temperatures between 36 and 38 8C, phosphate (pH 6.5
and 7.5) and ammonium acetate (pH 7.5) buffers, reaction
times in the range 1–48 h. However, the outcome was the
same in all cases: the amount of PAF(Acm2,Phacm2)-C1 de-
creased continuously and finally the peptide disappeared
from the reaction mixture. Our thinking was that nonspecific
binding of the relatively large and highly cationic PAF to
the carrier resin was responsible for the observation. To
prove the idea, PAF ACHTUNGTRENNUNG(Acm2,Fm2)-C1 was subjected to PGA
treatment at 37 8C in ammonium acetate buffer (pH 7.5).
The reaction was followed by HPLC. In spite of the fact
that PAF ACHTUNGTRENNUNG(Acm2,Fm2)-C1 does not contain the substrate of
PGA, the peptide disappeared from the reaction mixture at
about the same rate as PAF(Acm2,Phacm2)-C1. We tried to
liberate the peptide from the polymer using the following
procedures: repeated washing with either phosphate buffer
or 20% DMSO (dimethylsulfoxide) containing phosphate
buffer, treatment with acetic acid/ water (9:1) mixture and
sonication, dilution with 80% ethanol and sonication, wash-
ing with TFE (trifluoroethanol) and HFIP (hexafluoroiso-
propanol), treatment with 10 mm SDS (sodiumdodecylsul-
fate) solution. The filtrate was analyzed in each case, but
the peptide could not been detected in any of the solutions.
Figure 2. Sequences of the synthesized peptides. The short name PAF-L refers to the reduced form of full-
length PAF. P1–27 and P28–55 are the N- and C-terminal fragments, respectively, of PAF used for native
chemical ligation. The protecting groups of cysteine residues are indicated in the names of the peptides.
Figure 3. HPLC co-elution profile of PAF-C3 synthesized from PAF-
ACHTUNGTRENNUNG(Acm2,Fm2)-L and native PAF. Linear gradient: from 15 to 40% (solvent
system B) over 25 min. Flow rate: 1.0 mLmin1.
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Since immobilized PGA did not work for PAF, we tried to
circumvent the application of it by removing both the
Phacm and Acm group pairs with the use of iodine. The use
of iodine in acidic solution led to cleavage of the four pro-
tecting groups at the same time and formed two disulfide
bridges simultaneously. HPLC analysis revealed different re-
tention times for the product and natural PAF.
Folding of PAF by nonselective protection of cysteine resi-
dues : Different oxidation conditions were tested: a) the pep-
tide was dissolved in 20% acetic acid and shaken with
3 equivalents of iodine for 1 hour; b) the peptide was dis-
solved in 20% acetic acid containing 6m Gdn·HCl and
shaken with 3 equivalents of iodine for 1 hour; c) the pep-
tide was dissolved in 0.1m ammonium acetate buffer having
the pH of 7.5, 8.5, or 9.5 and subjected to air oxidation for
24 hours; d) the peptide was dissolved in 0.1m glycine
buffer, pH 10.5, and subjected to air oxidation for 24 hours;
e) the peptide was dissolved in 0.1m ammonium acetate
buffer and shaken with 30 equivalents of cross-linked ethox-
ylate acrylate resin (CLEAR-OX) support for 4 hours.[41]
The peptide concentration was 0.2 mgmL1 in all cases. All
the experiments showed a similar HPLC profile, and none
of them resulted in the correctly folded peptide. Notably,
the products of all attempts eluted from the reverse-phase
column slower, that is, had a larger retention time than
native PAF. Only one condition was found in which Cys res-
idues of PAF paired correctly: addition of both an SH-group
containing compound and an oxidizing agent to a solution
of the peptide.
The idea was inspired by the almost quantitative rear-
rangement of the disulfide bridges of misfolded a-conotoxin
GI.[42] In our most successful procedure, the peptide was dis-
solved in 0.1m ammonium acetate buffer (pH 7.5) at a
0.2 mgmL1 concentration and subjected to air oxidation
with intensive stirring in the presence of a catalytic amount
of cysteine (0.2 mgmL1; Figure 4). Oxidative folding with a
glutathione-based redox buffer (1 mm GSH and 1 mm GSSG
in 0.1m ammonium acetate buffer, pH 7.5) provided natural
pairing of cysteine residues with lower yield than the use of
the cysteine-O2 system (see the Supporting Information, Fig-
ure S31 and S32).
Identification of disulfide bridges by mass spectrometry :
Mass spectrometric methods for disulfide-bridge identifica-
tion are based on chemical and enzymatic methods (accord-
ing to the sequence of the protein or peptide), and produce
a mixture of peptides containing only one disulfide bond.
Fragments linked together through disulfide bridges are sep-
arated and analyzed by capillary reverse-phase HPLC cou-
pled to the mass spectrometer. The fragments can be identi-
fied based on their unique masses and tandem mass spectro-
metric fragments. The success of the procedure usually de-
pends on the reagents used for cleaving the peptide or pro-
tein at the half cystinyl residues. Based on the sequence of
PAF, a mixture of trypsin and chymotrypsin was found to be
a good choice. There is at least one cleavage site in this
enzyme cocktail (trypsin: at the N-terminus of K and R;
chymotrypsin at the N-terminus of F, W, Y) between every
two neighboring cysteine residues, hence mass spectrometric
analysis of PAF digestion can be used to find fragments
linked together through disulfide bridges. To confirm that
disulfide-linked fragments were derived from the examined
peptide, the mass list was compared to that of the reduced
form of the peptide: peaks belonged to peptide-derived SS
linked fragments were not present mass spectra of the re-
duced sample.
Figure 4. Oxidative folding of PAF-L in 0.1m NH4OAc buffer (pH 7.5) in
the presence of catalytic amount of cysteine A) after 1 h, and B) after
24 h reaction time. C) Co-injection of native PAF and the 24-h oxidative-
folding reaction mixture. Linear gradient: from 5 to 40% (solvent system
B) over 35 min. Flow rate: 1.0 mLmin1.
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Mass spectrometric analysis of PAFACHTUNGTRENNUNG(Acm2)-C2 showed di-
sulfide bridges between cysteine residues 14–28 and 43–54.
The most intense peaks and sequences of the digested
sample are summarized in the Supporting Information,
Table S1. The unnatural SS bond connectivity refers to the
most probable concurrent pattern of PAF. Mass spectrome-
try analysis supports rearrangement of previously formed di-
sulfide bonds under basic conditions.
Examination of native PAF and PAF-C3 successfully
proved the supposed disulfide connectivity, thus, the pres-
ence of SS bonds between cysteine residues 7–36, 14–43,
and 28–54. Ion chromatograms of the digested samples and
disulfide-bonded peptide fragments are shown in Figure 5.
The results are presented in more details in the Supporting
Information, Tables S3 and S4. While more hits were found
for the most intense peaks (peptide fragments containing a
SS bond between cysteine residues 14–43 and 28–54), only
one peptide confirmed the existence of the Cys7,36 bridge
(CTKSK=DNKKCTK). This can be explained by the fact
that the peptide resulting from complete enzymatic diges-
tion (CTK=CTK) is too small and polar to be retained by
the trapping column of the HPLC system.
The HPLC retention times of natural PAF and PAF-C3
were similar to each other. Both peptides showed high
enzyme resistance, that is, even after 12 hours of proteolytic
digestion, a significant amount of undigested peptide was
found in the samples. Enzyme resistance can be the conse-
quence of inaccessible cleavage sites. This high enzyme re-
sistance was not shown by other synthetic PAF variants
having unnatural disulfide-bridge patterns. Supposedly, mis-
folded PAF does not adopt a three-dimensional structure in
which the cleavage sites are buried.
NMR investigations : Some time ago we investigated[6] the
structure, dynamics, and target-recognition aspects of the
antifungal protein PAF (from Penicillium chrysogenum).
Having a cationic nature owing to thirteen lysine residues
and still exhibiting amphipathic character, it is an excellent
antifungal protein model. Our structural analysis[6] (pdb
code: 2kcn) by NMR spectroscopy showed that the tertiary
structure of PAF is stabilized by three disulfide bonds. The
present comparative studies on native, synthetic linear, and
synthetic folded PAFs were carried out using 1H,
1H NOESY and 1H–13C HSQC experiments. Linear PAF is
surprisingly stable in solution (under Ar atmosphere) and is
in an unfolded state, as shown by the 1H and 13C spectral
pattern (see the Supporting Information, Figure S31). After
approximately six weeks in solution, spontaneous refolding
of PAF-L into native PAF becomes apparent (the doublets
corresponding to Valine 45 appearing in the range 0.43–
0.46 ppm being indicative); however folding stops at a very
low concentration of folded protein. The well-folded struc-
ture of native PAF could be obtained by the oxidation as de-
scribed above. NMR spectroscopy confirms the identity of
native and synthetic folded PAF. The amide region of the
1H NMR spectrum of synthetic folded PAF is the mirror
image of that of the inverted spectrum of native PAF
(Figure 6).
The 13C–1H correlation maps of the two proteins are virtu-
ally identical (Figure 7), data that further confirms the iden-
tity of the two proteins including the disulfide pattern and
the 3D structure.
Figure 5. Identification of disulfide bridges A) in native PAF and B) in
PAF-C3 by mass spectrometry. Base ion chromatogram of the enzyme-di-
gested PAF (a) and different ion chromatograms (b–f) correspond to di-
sulfide-bonded peptides found by analysis of mass lists are shown.
Figure 6. Amide-proton region of the 1H NMR spectra of synthetic (top)
and native (bottom) PAF.
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Antifungal activity assay : Antifungal susceptibility tests re-
vealed that the in vitro antifungal activity of PAF-C3 toward
filamentous fungi is the same as that exerted by native PAF.
The minimal inhibitory concentrations (MICs) of both
native PAF and PAF-C3, as determined using a microtiter
plate bioassay, were 12.5 mgmL1, 6.25 mgmL1, and
50 mgmL1 with respect to A. nidulans FGSC26, A. niger
SZMC 601, and T. longibrachiatum UAMH 7955, respective-
ly. These corresponding data for the agar diffusion test were
12.5 mgmL1, 25 mgmL1, and 12.5 mgmL1, respectively. The
differences in the MICs from the two different applied sus-
ceptibility tests in case of the same species are the conse-
quence of the differences in the applied two techniques.
One of them is a dilution technique in which the conidia are
submerged in the PAF solution, in this case every conidium
is affected by the PAF. In the diffusion technique not all ino-
culated conidia are affected by the PAF solution, only those
in the diffusion zone of the protein solution. Because re-
duced glutathione (GSH) exists at a concentration of ap-
proximately 5 mm in animal cells, we investigated the anti-
fungal effect of PAF-L in the presence of GSH; GSH main-
tains PAF-L in the linear form. PAF-L did not show a
growth inhibitory effect against all of the investigated fungal
strains both in the presence of 5 mm GSH and the absence
of it, thus indicating that this form of PAF is antifungally in-
active (see the Supporting Information, Figure S34). The
presence of 5 mm GSH did not have any influence on the
antifungal activity of native PAF; the observed MIC values
were the same as those measured in the absence of GSH
(data not shown). The MIC data of our antifungal suscepti-
bility tests indicate that the in vitro antifungal activity of
PAF-C3 on filamentous fungi is at a similar level to that ex-
erted by native PAF. The manifestation of the antifungal
effect of PAF-C3 is practically identical to that observed
previously for PAF:[43] PAF-C3 also caused inhibition of
spore germination and retardation of hyphae lengthening at
a level depending on its applied concentration. The devel-
oped hyphae were very short, swollen, curved, and had mul-
tiple branches compared to the untreated control (see the
Supporting Information, Figure S36).
Conclusion
Increasing interest in multiple-disulfide-containing polypep-
tides and small proteins has led to an extensive search for
suitable routes for their synthesis. However, careful synthet-
ic planning is required; for example, selective reduction of
sulfur-based tert-butyl groups in the presence of disulfides
can be problematic.[44] According to our results, removal of
Fm can lead to disulfide rearrangement and the application
of the newly developed, enzyme-cleavable Phacm group is
restricted owing to adsorption of larger peptides to the carri-
er resin.
The disulfide pattern of PAF was confirmed using differ-
ent methods. First, homology (with AFP) and bioinformatics
studies selects the abcabc pattern as being the most proba-
ble. Second, folding of linear PAF leads to a native PAF
structure. Third, mass spectroscopy studies of synthetic
products (non-native disulfide patterns) excluded some con-
current patterns and confirmed the native one. Fourth, on-
going extended NMR structural studies (to be published)
are more consistent with the abcabc disulfide-bond pattern.
Herein, linear PAF did not exhibit an antimicrobial effect
either under oxidative or reductive conditions. Previous
studies demonstrated that the proper folding of the PAF is
required for optimal activity and its highly conserved and
positively charged lysine-rich surface region plays a central
role in the toxicity of PAF towards target organisms.[6,45]
Based on our observations, the proper conformation of PAF
was not obtained from its linear form under reductive condi-
tions and the level of proper folding under oxidative condi-
tions is too low for exertion of the antifungal effect.
Synthetic PAF and derivatives thereof are interesting sub-
jects for further folding studies, for studies on the mode of
action of antifungal proteins, and for potential pharmaceuti-
cal applications.
Experimental Section
Peptide synthesis and purification : Peptides were prepared using solid-
phase synthesis. The stepwise synthesis of PAF was carried out either on
a Liberty microwave peptide synthesizer (CEM Corporation, USA) by
using Fmoc chemistry and HBTU/HOBt coupling protocols, or by man-
ually using Boc chemistry and DCC/HOBt coupling protocols. PAF frag-
ments for native chemical ligation were synthesized manually by using
Boc chemistry. The C-terminal fragment (P28–55) was prepared by using a
standard DCC/HOBt coupling protocol. The N-terminal fragments (P1–27)
were synthesized as follows. First, Fmoc-Cys ACHTUNGTRENNUNG(Trt)-OH was attached to
MBHA resin by using DCC/HOBt coupling. After that, the Fmoc group
was cleaved by using 20% piperidine/DMF and the resulting free amino
group was acetylated using 30% acetic anhydride/CH2Cl2. Then the trityl
Figure 7. Overlaid 2D 13C-HSQC NMR spectra of the synthetic (red) and
native (blue) PAF. Expanded view of the aromatic (7.5–5.5 ppm) and ali-
phatic Me region (0–1.8 ppm) is shown in the frames. The ppm scales of
the two spectra are slightly shifted for better comparison of overlapping
signals.
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group was cleaved by treatment with TFA containing 5% (v/v) H2O and
5% (v/v) DTT for a period of 2 h. The C-terminal lysine was attached to
the free sulfhydryl group of cysteine by applying DCC/HOBt double cou-
pling in the presence of 4-DMAP. The synthesis of the rest of the peptide
was carried using standard DCC/HOBt protocols. The crude peptides
were purified by semipreparative RP-HPLC by using a solvent system of
(A) 0.1% TFA and (B) 80% ACN, 0.1% TFA. The purity of the pepti-
des was evaluated by analytical RP-HPLC and integrity of the products
was verified by mass spectrometry by using a Finnigan TSQ 7000 tandem
quadrupole mass spectrometer equipped with electrospray ion source.
More detailed procedures are presented in the Supporting Information.
Native chemical ligation : The ligation of peptide fragments was per-
formed in 0.1m ammonium acetate buffer (pH 7.5) containing 3% thio-
phenol at 6–8 mgmL1 peptide concentration at 25 8C. The reaction was
monitored by analytical RP-HPLC. The ligation reached completion in
4–5 h in all cases. The precipitate was dissolved with the addition of 10–
15% ACN and guanidine hydrochloride (6m final concentration). The re-
action mixture was filtered and purified by semipreparative RP-HPLC.
Oxidative folding of PAF : The linear peptide (PAF-L) was dissolved at a
concentration of 0.2 mgmL1. The conditions that resulted in misfolding
of the protein are discussed in detail in the Results and Discussion Sec-
tion. In the experiment that led to a natural disulfide bridge pattern,
linear PAF was dissolved in 0.1m NH4OAc buffer having the pH of 7.5 at
a concentration of 0.2 mgmL1. A catalytic amount of cysteine was
added to the mixture and the resulting mixture was stirred intensively for
24 h at room temperature. Aliquots were taken at different times and
checked by analytical HPLC. The mixture was then lyophilized three
times and the final product was purified by semipreparative HPLC.
MS investigations : Samples were subjected to digestion with trypsin and
chymotrypsin for 6 h at 37 8C. The digestion time was relatively short in
order to keep rearrangement of disulfide bridges at a low level. The di-
gested samples were analyzed on a Waters NanoAcquity UPLC system
coupled with a Micromass Q-TOF premier mass spectrometer. 30-min-
long gradients from 3 to 40% acetonitrile/water were applied on a
Waters BEH130 C18 75 mm250 mm column with 1.7 mm particle size
and C18 packing. The mass spectrometer was operated in MSE mode
with lockmass correction (standard: Glu-1-Fibrinopeptide [M+2H+]
m/z=785.842). All acquired data were processed and peak lists were gen-
erated by the WATERS Proteinlynx 2.3 software. The resulting peak lists
were sorted according to their intensities and analyzed with disulfide-
bridge analyzer software.[46]
NMR spectroscopy: Typically, 1 mg protein (native PAF, linear synthetic
PAF-L, and folded synthetic PAF-C3) was dissolved in 275 ml buffer
(93:7 H2O/D2O, 20 mm Na3PO4, pH 6, 40 mm NaCl, 0.04% NaN3). The
NMR spectra of protein solutions were measured in Shigemi NMR tubes
at 298 K. The folded synthetic and native PAF did not show any decom-
position within a timeframe of one year; PAF-L started to spontaneously
fold after a month. 1H chemical-shift scales are referenced to sodium 2,2-
dimethyl-2-silapentane-5-sulfonate (0 ppm) and heteronuclear shifts are
referenced indirectly from the gyromagnetic ratios for 15N and 13C, thus
giving 67.1 ppm for the dioxane 13C signal. The NMR spectra were re-
corded on an Avance II-500 (Bruker, Rheinstetten, Germany) spectrome-
ter. Water signal suppression was achieved using the watergate5 se-
quence.[47] Natural abundance 13C–1H HSQC spectra were acquired typi-
cally in overnight experiments. 1H and 13C hard-pulse length were in the
10–12/13—16 ms range, respectively. Radiation-damping-suppressed
2D NOESY (130 ms mixing time) spectra were acquired in 2048·512
points and transformed to 4096·2048 points.
Bioinformatics : Some public bioinformatics tools (DISULFIND server)
were applied for PAF disulfide pattern prediction.[48,49]
Antifungal activity assay : The minimal inhibitory concentrations (MIC)
of native PAF, its synthetic form (PAF-C3), and PAF-L against PAF-sen-
sitive Aspergillus nidulans (Fungal Genetic Stock Center, Kansas City,
MO, USA; FGSC26), Aspergillus niger (Szeged Microbial Collection,
University of Szeged, Szeged, Hungary; SzMC 601), and Trichoderma
longibrachiatum (University of Alberta Microfungus Collection and Her-
barium, Alberta, Canada; UAMH 7955)[50,51] were determined by using a
96-well microtiter-plate bioassay and an agar-diffusion method using a
low-cationic medium (LCM; 2 gL1 glucose, 0.1 gL1 yeast extract,
0.05 gL1 peptone, 2 gL1 agar if necessary and supplemented with
2.5 mgL1 biotin in case of A. nidulans FGSC26).
In the 96-well microtiter-plate bioassays, 100-mL solutions of PAF, PAF-
C3, or PAF in 50 mm Tris-HCl/OH buffer pH 7.2 was mixed with 100 mL
of conidial suspension (106 conidia/mL) prepared in double concentrated
(2106 condia per ML) LCM broth. In the cases of native PAF and PAF-
L, peptides dissolved in the same buffer containing 5 mm of reduced l-
glutathione (GSH, Sigma–Aldrich) were also tested. GSH helps maintain
the linear form of PAF-L. The final concentrations of the peptides were
50, 25, 12.5, 6.25, and 3.125 mgmL1. The plates were incubated at 25 8C
and the optical densities were then measured at 620 nm with a microtit-
er-plate reader (ASYS Jupiter HD-ASYS Hitech) after 48 h. Fresh LCM
broth was used as a background for the spectrophotometric calibration.
To determinate the MIC values, optical densities of the untreated control
cultures (100 mL buffer+100 mL conidia suspension) were referenced to
100% of growth, in each case. The MIC was defined as the lowest anti-
fungal peptide concentration at which growth was not detected on the
basis of the OD620 values as compared with the untreated control.
In the case of the agar diffusion technique, solid LCM was inoculated
with 106 conidia/mL and 100-mL aliquots of serial peptide dilutions (50,
25, 12.5, and 6.25 mgmL1), as used in microtiter-plate bioassay, were
added into wells. The diameters of the inhibition zones were measured
after incubation for 48 h at 25 8C. The MIC was defined as the lowest an-
tifungal peptide concentration at which inhibition zone appeared around
the well. Sterile buffer without protein was used as a negative control in
this experiment.
Antifungal activity assays were repeated three times.
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